• email
  • rss
  • twitter
  • facebook
  • linkedin
  • News
  • Investors
  • Contact

Ceapro Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Quality Management System
    • Sustainability
  • Technologies
    • Overview
    • Ethanol Fractionation Processes
    • Pressurized Gas Expanded (PGX) Technology
    • Chromatography Purification
    • Intellectual Property
    • Scientific Publications
  • Pipeline
    • Overview
    • Oat Beta Glucan
    • Avenanthramides
    • Product Brochures
  • Cosmeceuticals
    • Overview
  • Nutraceuticals
    • Overview
    • Oat Beta Glucan
    • Avenanthramides
  • Business Development
    • Overview
    • Partners
  • News
  • Investors
  • Contact
  • Home
  • News
  • Press Releases
Navigation
  • Press Releases
  • Media Coverage

Press Releases

  • All News
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007

Ceapro Inc. Reports Fourth Quarter and Full Year 2019 Results and Highlights

April 16, 2020

Ceapro Inc. to Present at the April 2020 Virtual Investor Summit

April 15, 2020

Ceapro Inc. Receives Research License from Health Canada Controlled Substances and Cannabis Branch

February 14, 2020

Ceapro Inc. to Present at Noble Capital Markets’ 16th Annual Investor Conference

February 10, 2020

Ceapro Inc. Announces Approval from Health Canada for Protocol Expansion of Current Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent

February 5, 2020

Ceapro Inc. Secures DTC Eligibility for Publicly Traded Shares Under Ticker OTCQZ: CRPOF

January 31, 2020

Ceapro Announces Grant of Stock Options and Restricted Share Units

January 6, 2020

Ceapro Inc. Announces Publication of Results for a New PGX Processed Chemical Complex in the Journal of Supercritical Fluids

December 17, 2019

Ceapro Inc. Reports 2019 Third Quarter Financial Results and Operational Highlights

November 13, 2019

Ceapro Inc. Announces Issuance of U.S. and European Patent for Flagship Product, Avenanthramides

October 29, 2019

  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...25
  • Next »

Sign up for email ALERTS Be the first to receive news and updates on Ceapro. Sign Up

  • © 2023 Ceapro Inc.
  • Privacy Policy
  • Disclaimer
  • Sitemap